Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study.

scientific article published on 22 June 2015

Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5114/PWKI.2015.52282
P932PMC publication ID4495125
P698PubMed publication ID26161101
P5875ResearchGate publication ID279986877

P50authorKrzysztof ŻmudkaQ68692834
Wojciech SzotQ73728921
Marcin MajkaQ88841239
Piotr MusialekQ92838989
Lukasz TekieliQ114310827
Mariusz TrystulaQ114310832
Andrzej KadzielskiQ114310901
Robert Paweł BanyśQ114448943
Jacek KijowskiQ116690048
Piotr PodolecQ59188258
Magdalena KostkiewiczQ62591429
P2093author name stringAdam Mazurek
Danuta Jarocha
Malgorzata Urbanczyk
P2860cites workStem cell treatment for acute myocardial infarctionQ24203736
Use of mesenchymal stem cells for therapy of cardiac diseaseQ27003127
Malignant transformation potentials of human umbilical cord mesenchymal stem cells both spontaneously and via 3-methycholanthrene inductionQ28536701
Mesenchymal stem cells in the Wharton's jelly of the human umbilical cordQ30160386
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient dataQ30896351
Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanismsQ33746675
Bioartificial heart: a human-sized porcine model--the way aheadQ34445550
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trialsQ34469147
Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activityQ34544884
Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative studyQ34586865
Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?Q34803754
[Visualisation of early engraftment of transcoronary applied CD34+ cells in the infarct border zone]Q80676593
Early myocardial engraftment of autologous CD34+ cells administered transcoronary via a physiological cell-delivery systemQ81747722
Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: the rationale and a pilot study involving a comparison with conventional over-the-wire balloon coronary occlusions in patients after recent myocardial inQ83921613
Experimental cell therapy: the search for the best stem cell continuesQ85815033
A critical challenge: Dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarctionQ86733086
Immune properties of human umbilical cord Wharton's jelly-derived cellsQ34808849
Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challengesQ34981433
Comparative quantification of the surfaceome of human multipotent mesenchymal progenitor cells.Q35222594
Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial InfarctionQ35883152
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trialQ36603453
Stem cells for reprogramming: could hUMSCs be a better choice?Q36683536
Umbilical cord cells as a source of cardiovascular tissue engineeringQ36712785
Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cellsQ36906533
Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?Q38064659
The Therapeutic Potential, Challenges and Future Clinical Directions of Stem Cells from the Wharton’s Jelly of the Human Umbilical CordQ38066801
New Frontiers in Regenerative Medicine in Cardiology: The Potential of Wharton’s Jelly Mesenchymal Stem CellsQ38070807
Tracking gene and cell fate for therapeutic gainQ38180960
Common Expression of Stemness Molecular Markers and Early Cardiac Transcription Factors in Human Wharton's Jelly-Derived Mesenchymal Stem Cells and Embryonic Stem CellsQ38317834
Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model.Q40230482
Fever in myocardial infarction: is it still common, is it still predictive?Q40279771
FDA regulation of stem-cell-based therapiesQ43719914
Human umbilical cord perivascular cells exhibit enhanced cardiomyocyte reprogramming and cardiac function after experimental acute myocardial infarction.Q43765659
TASTE-less endpoint of 30-day mortality (and some other issues with TASTE) in evaluating the effectiveness of thrombus aspiration in STEMI: not the "evidence" to change the current practice of routine consideration of manual thrombus extractionQ45037457
Intracoronary Infusion of Allogeneic Mesenchymal Precursor Cells Directly After Experimental Acute Myocardial Infarction Reduces Infarct Size, Abrogates Adverse Remodeling, and Improves Cardiac FunctionQ47236219
Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imagingQ47264225
Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarctionQ48619654
Integration properties of Wharton's jelly-derived novel mesenchymal stem cells into ventricular slices of murine heartsQ50673940
Human umbilical cord cells for cardiovascular tissue engineering: a comparative studyQ51699232
Wharton’s jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarctionQ53096877
Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injuryQ53152611
Cardiopoietic Stem Cell Therapy in Heart FailureQ57779306
ReplyQ57779316
Microvascular Obstruction by Intracoronary Delivery of Mesenchymal Stem Cells and Quantification of Resulting Myocardial Infarction by Cardiac Magnetic ResonanceQ61480032
P433issue2
P921main subjectmesenchymal stem cellQ1922379
acute myocardial infarctionQ18558122
P304page(s)100-107
P577publication date2015-06-22
P1433published inPostępy w Kardiologii InterwencyjnejQ26853806
P1476titleMyocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study
P478volume11

Reverse relations

cites work (P2860)
Q41015957Cardioprotective Effects of Wharton Jelly Derived Mesenchymal Stem Cell Transplantation in a Rodent Model of Myocardial Injury.
Q58555709Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies
Q92394704Cellular Therapy for Ischemic Heart Disease: An Update
Q38610604Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications.
Q41691710Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer
Q26748751Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015)
Q89133396Retrieval of a periodontally compromised tooth by allogeneic grafting of mesenchymal stem cells from dental pulp: A case report
Q64947688Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta-Analysis.
Q57301701Temporal changes in the pattern of invasive angiography use and its outcome in suspected coronary artery disease: implications for patient management and healthcare resources utilization
Q90279588The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
Q90615041The use of large animals to facilitate the process of MSC going from laboratory to patient-'bench to bedside'

Search more.